Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,569.20
(
0.00%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
104.38
(
2.22%
)
Bitcoin
76,836.31
(
-0.69%
)
News Focus
News Focus
Post# of 4929
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122891
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: fung_derf post# 456

Thursday, 04/24/2014 2:24:41 PM

Thursday, April 24, 2014 2:24:41 PM

Post# of 4929

You sure do spend a lot of time here putting down this stock.

I would restate that by saying that I’ve highlighted some of the risks to GILD’s valuation that other posters may be underplaying—see #msg-101066614.

Sovaldi is an awesomely great drug, but GILD has a market cap of >$110B and it consists of a lot of moving parts. It’s reasonable to be thinking about what could go wrong.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GILD News
More GILD News